EHMT2 and rhabdomyosarcoma: In rhabdomyosarcoma cells, inhibition and knockdown of G9a reduce the activation of Akt, which is a downstream effector of PI3K [70]; however, the impact of G9a on PI3K/Akt signaling in response to TGFβ1 has not been elucidated.